Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes
about
Poliovirus cell entry: common structural themes in viral cell entry pathwaysComplexes of poliovirus serotypes with their common cellular receptor, CD155Crystal structure of CD155 and electron microscopic studies of its complexes with poliovirusesStructure of human enterovirus 71 in complex with a capsid-binding inhibitorMore-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding moleculesA novel benzonitrile analogue inhibits rhinovirus replicationAntiviral activity of 3(2H)- and 6-chloro-3(2H)-isoflavenes against highly diverged, neurovirulent vaccine-derived, type2 poliovirus sewage isolatesStructure Elucidation of Coxsackievirus A16 in Complex with GPP3 Informs a Systematic Review of Highly Potent Capsid Binders to EnterovirusesRNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectorsMolecular tectonic model of virus structural transitions: the putative cell entry states of poliovirusCo-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.Coxsackievirus A9 VP1 mutants with enhanced or hindered A particle formation and decreased infectivityInteraction of coxsackievirus A21 with its cellular receptor, ICAM-1.Effect of formaldehyde inactivation on poliovirusStructure and inhibition of EV-D68, a virus that causes respiratory illness in children.Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicityEvolution of type 2 vaccine derived poliovirus lineages. Evidence for codon-specific positive selection at three distinct locations on capsid wall.Characteristics of an environmentally monitored prolonged type 2 vaccine derived poliovirus shedding episode that stopped without interventionNectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014.Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines.Characterization of poliovirus variants selected for resistance to the antiviral compound V-073.The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1Characterization of the New World monkey homologues of human poliovirus receptor CD155.Virucidal efficacy of glutaraldehyde against enteroviruses is related to the location of lysine residues in exposed structures of the VP1 capsid protein.A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine PoliovirusShedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord.Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating.Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus.Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children.Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
P2860
Q24550839-3D24D67A-67A0-403B-AAA2-82A583454ED9Q24554469-6C977183-34C6-4D3D-9201-E7D1F9435FC5Q24653737-41B31629-8CA3-4240-84DF-1D44B3D9346FQ27676881-9099A7BA-B9A3-49EA-9A9A-9EF3F327DCF9Q27681644-7FA7C47F-B31D-403F-A7F2-EA1CCC163D9EQ27690771-224466B7-93D8-42AF-9F9A-20672E6A6EA3Q28478276-8106D6F8-F731-4F2F-90EB-D544466833FBQ28550382-31FE1F01-E647-4A4C-AE9B-D601D566D11DQ28709097-D9AEEFAC-6845-4A2F-A031-35AFB55201C0Q30175274-A1DBFFDA-576B-4C17-845B-C082AF84206DQ33310740-C9F4D0D5-19A9-4583-ACC0-73E847443802Q33346729-168C014D-6B76-4EDF-8A19-7890A24C0322Q33835763-6B780956-965C-4195-828B-F3EC1F004974Q33850847-FDAFADD5-5C57-4A5F-95C2-FE0D4CAFE404Q34261625-4A9F337B-F6CB-4212-9271-7650CEF53474Q34456331-AFBD1A5D-903A-4F4C-82C0-3E8450DAC4C4Q34545765-26508966-237D-4C52-9ED6-A3D37EA0CF84Q34632891-14737D4B-DE07-4325-B7F8-34FCA3D0C58FQ34806015-B39ED468-9F60-4F53-AD9C-89A6CAEE6552Q34917653-4B27AE62-5359-4289-B437-CB4E206B00ADQ35641030-17ED7DDA-10D2-436C-9500-FB6C52F79169Q35757398-A2D8B06A-64B3-4697-9B8E-FD9C42FF2C25Q35971462-007D2514-BB31-4A38-A38D-2F942A3240BFQ36254152-B02E7B35-941A-4D95-9731-25D0C122B48BQ36364228-FE3BAB02-CE4A-4B36-BB59-4D4B34BE57E9Q36389012-46E15E6B-6484-41AF-BE16-24E41938D68DQ36600425-2ADD94EE-82B4-4422-92A7-09B4A90F3A8FQ36747721-677BBBDE-4CBA-439C-A0E8-6D96C18AA6C5Q36930107-05BDCACD-E422-439E-86F6-9C3438327C29Q37002529-42E23FB3-5C9F-4982-80DC-D03672CDD3FBQ37333852-3A2DA172-D00C-4E02-8A8D-AE75F871FE35Q39605445-39DD4C5F-BF36-4DBC-A342-95F853827A94Q40163296-85D15BE6-4AC0-474B-8B95-4AFBAC0671C8Q40624814-948F931F-DD12-4E2D-9E9D-76BF148FC43DQ40882626-86156282-F5EC-45DF-AA9F-A065F3F2293AQ41416634-100D6C69-FCF3-4220-8EDC-6811F90C8FD6Q50042232-90A59239-CCB1-4FD7-B0E3-EAB62540743D
P2860
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@ast
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@en
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@nl
type
label
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@ast
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@en
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@nl
prefLabel
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@ast
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@en
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@nl
P2093
P3181
P1433
P1476
Structure of poliovirus type 2 ...... of three poliovirus serotypes
@en
P2093
J DeMartino
J O'Connell
J Schwartz
P Buontempo
S C Geisler
P304
P3181
P356
10.1016/S0969-2126(97)00249-9
P577
1997-07-15T00:00:00Z